Prevalence of new psychoactive substances in oral fluid samples from French drivers

A longitudinal survey (2016–2020)
Auteur(s)
Richeval, C.; Gish, A.; Hakim, F.; Nachon-Phanithavong, M.; Wiart, J.-F.; Humbert, L.; Allorge, D.; Gaullier, J.-M.
Jaar

Currently, standard roadside testing in France is performed in oral fluid (OF) using an on-site immunological screening for drugs of abuse (DOA), specifically the Drugwipe-5S® from Securetec (OF screening test for ecstasy/amphetamine, opiates, cocaine and cannabis). In 2016 and in 2017, we tested French and Belgian drivers’ OF samples for new psychoactive substances (NPS) after a positive or negative roadside screening test for DOA. Here, we complete these data by updated results in French drivers’ OF sampled in 2018, 2019 and 2020.

Publicatie aanvragen

3 + 0 =
Los deze eenvoudige rekenoefening op en voer het resultaat in. Bijvoorbeeld: voor 1+3, voer 4 in.
Pagina's
e20-e21
Verschenen in
Journal of Analytical Toxicology
45 (6)
Bibliotheeknummer
20220003 ST [electronic version only]

Onze collectie

Deze publicatie behoort tot de overige publicaties die we naast de SWOV-publicaties in onze collectie hebben.